Literature DB >> 12199350

Impact of endocrine hyperfunction and phosphate wasting on bone in McCune-Albright syndrome.

R Lala1, P Matarazzo, M Andreo, C Defilippi, C de Sanctis.   

Abstract

Skin dysplasia, as café-au-lait spots, bone fibrous dysplasia and peripheral endocrinopathies are the main clinical features of McCune-Albright syndrome (MAS). This illness is due to activating mutations of the Gsalpha protein and is spread with a mosaic pattern in affected tissues that consist of intermixed areas of normal and mutated cells. Peripheral endocrine secretion, free of hypothalamic pituitary control, is the hallmark of the endocrine syndromes: precocious puberty, Cushing's syndrome, hyperthyroidism and gigantism/acromegaly. In addition, phosphate wasting as hyperphosphaturia is often present. The impact of hormonal hypersecretion and phosphate loss on the bones of patients with MAS is poorly understood both in normal and fibrous bone tissue. As hypercortisolism and hyperthyroidism increase bone resorption, hyperestrogenism and growth hormone hypersecretion stimulate bone growth and mineralization, and phosphate wasting reduces bone mineral content. All these actions can be exerted at varying times and degrees in a single patient on lesional and non-lesional bones. Sonographic evidence of multiple diffused hyperechogenic spots in the testes of patients with MAS do not seem to be related to alterations in calcium-phosphate metabolism but rather to zonal dysplasia/hyperplasia of testicular tissue.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12199350

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  3 in total

1.  Our experience in the surgical management of craniofacial fibrous dysplasia: what has changed in the last 10 years?

Authors:  V Valentini; A Cassoni; V Terenzi; M Della Monaca; M T Fadda; O Rajabtork Zadeh; I Raponi; A Anelli; G Iannetti
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-10       Impact factor: 2.124

2.  Cushing syndrome in the McCune-Albright syndrome.

Authors:  Rebecca J Brown; Marilyn H Kelly; Michael T Collins
Journal:  J Clin Endocrinol Metab       Date:  2010-02-15       Impact factor: 5.958

3.  Clinical guidelines for the management of craniofacial fibrous dysplasia.

Authors:  J S Lee; E J FitzGibbon; Y R Chen; H J Kim; L R Lustig; S O Akintoye; M T Collins; L B Kaban
Journal:  Orphanet J Rare Dis       Date:  2012-05-24       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.